P-selectin-targeted nanocarriers induce active crossing of the blood–brain barrier via caveolin-1-dependent transcytosis

DE Tylawsky, H Kiguchi, J Vaynshteyn, J Gerwin… - Nature materials, 2023 - nature.com
Medulloblastoma is the most common malignant paediatric brain tumour, with~ 30%
mediated by Sonic hedgehog signalling. Vismodegib-mediated inhibition of the Sonic …

Breaking barriers: exploring mechanisms behind opening the blood–brain barrier

MEM Stamp, M Halwes, D Nisbet, DJ Collins - Fluids and Barriers of the …, 2023 - Springer
The blood–brain barrier (BBB) is a selectively permeable membrane that separates the
bloodstream from the brain. While useful for protecting neural tissue from harmful …

Photodynamic opening of the blood–brain barrier and the meningeal lymphatic system: the new niche in immunotherapy for brain tumors

O Semyachkina-Glushkovskaya, A Terskov… - Pharmaceutics, 2022 - mdpi.com
Photodynamic therapy (PDT) is a promising add-on therapy to the current standard of care
for patients with glioblastoma (GBM). The traditional explanation of the anti-cancer PDT …

Intranasal delivery of liposomes to glioblastoma by photostimulation of the lymphatic system

O Semyachkina-Glushkovskaya, A Shirokov, I Blokhina… - Pharmaceutics, 2022 - mdpi.com
The blood–brain barrier (BBB) limits the delivery of majority of cancer drugs and thereby
complicates brain tumor treatment. The nasal-brain-lymphatic system is discussed as a …

[HTML][HTML] Photodynamic therapy for glioblastoma: a light at the end of the tunnel

M Miretti, MAG Graglia, AI Suárez, CG Prucca - Journal of Photochemistry …, 2023 - Elsevier
Glioblastomas (GBM) are considered one of the most aggressive tumors of the central
nervous system. The standard treatment for GBM-diagnosed patients implies surgery …

Model systems for studying the blood-brain barrier: Applications and challenges

S Jackson, C Meeks, A Vézina, RW Robey, K Tanner… - Biomaterials, 2019 - Elsevier
The blood-brain barrier (BBB) poses a serious impediment to the delivery of effective
therapies to the central nervous system (CNS). Over time, various model systems have been …

Trajectory of brain-derived amyloid beta in Alzheimer's disease: where is it coming from and where is it going?

N Liu, A Haziyihan, W Zhao, Y Chen… - Translational …, 2024 - Springer
Alzheimer's disease (AD) is a progressive neurological disorder that primarily impacts
cognitive function. Currently there are no disease-modifying treatments to stop or slow its …

Photomodulation of lymphatic delivery of liposomes to the brain bypassing the blood-brain barrier: new perspectives for glioma therapy

O Semyachkina-Glushkovskaya, I Fedosov… - …, 2021 - degruyter.com
The blood-brain barrier (BBB) has a significant contribution to the protection of the central
nervous system (CNS). However, it also limits the brain drug delivery and thereby …

Delivery and kinetics of immersion optical clearing agents in tissues: Optical imaging from ex vivo to in vivo

T Yu, X Zhong, D Li, J Zhu, VV Tuchin, D Zhu - Advanced Drug Delivery …, 2024 - Elsevier
Advanced optical imaging provides a powerful tool for the structural and functional analysis
of tissues with high resolution and contrast, but the imaging performance decreases as light …

Novel approaches used to examine and control neurogenesis in Parkinson′ s disease

AB Salmina, MR Kapkaeva, AS Vetchinova… - International Journal of …, 2021 - mdpi.com
Neurogenesis is a key mechanism of brain development and plasticity, which is impaired in
chronic neurodegeneration, including Parkinson's disease. The accumulation of aberrant α …